Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Armand

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Cancer Research|February 15, 1992
Quantitative mapping of 4'-iododeoxyrubicin in metastatic squamous cellcarcinoma by secondary ion mass spectrometry (SIMS) microscopyP Fragu, J Klijanienko, D Gandia, et al.
Science (New York, N.Y.)|February 1, 1974
Inhibition of cellular mediated immunity in marihuana smokersG G Nahas, N Suciu-Foca, J P Armand, et al.
Neuroimaging Clinics of North America|August 1, 1997
Magnetization transfer imaging in AIDS-related brain diseasesV Dousset, J P Armand, P Huot, et al.
American Journal of Clinical Oncology|June 1, 1996
Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neckM E Bensmaine, N Azli, C Domenge, et al.
Bulletin Du Cancer|September 25, 2001
[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer]M Ducreux, K Fizazi, J F Seitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolitesJ Bernadou, B Monsarrat, H Roche, et al.
Clinical Chemistry|June 1, 1985
Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonanceJ Bernadou, J P Armand, A Lopez, et al.
Investigational New Drugs|January 1, 1987
Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometryM C Malet-Martino, P Servin, J Bernadou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Excretion of doxifluridine catabolites in human bile assessed by 19F NMR spectrometryR Martino, J Bernadou, M C Malet-Martino, et al.
Rapid Communications in Mass Spectrometry : RCM|January 1, 1995
Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometryI Royer, P Alvinerie, J P Armand, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Cancer Research|February 15, 1992
Quantitative mapping of 4'-iododeoxyrubicin in metastatic squamous cellcarcinoma by secondary ion mass spectrometry (SIMS) microscopyP Fragu, J Klijanienko, D Gandia, et al.
Science (New York, N.Y.)|February 1, 1974
Inhibition of cellular mediated immunity in marihuana smokersG G Nahas, N Suciu-Foca, J P Armand, et al.
Neuroimaging Clinics of North America|August 1, 1997
Magnetization transfer imaging in AIDS-related brain diseasesV Dousset, J P Armand, P Huot, et al.
American Journal of Clinical Oncology|June 1, 1996
Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neckM E Bensmaine, N Azli, C Domenge, et al.
Bulletin Du Cancer|September 25, 2001
[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer]M Ducreux, K Fizazi, J F Seitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolitesJ Bernadou, B Monsarrat, H Roche, et al.
Clinical Chemistry|June 1, 1985
Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonanceJ Bernadou, J P Armand, A Lopez, et al.
Investigational New Drugs|January 1, 1987
Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometryM C Malet-Martino, P Servin, J Bernadou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Excretion of doxifluridine catabolites in human bile assessed by 19F NMR spectrometryR Martino, J Bernadou, M C Malet-Martino, et al.
Rapid Communications in Mass Spectrometry : RCM|January 1, 1995
Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometryI Royer, P Alvinerie, J P Armand, et al.
Pageof 15